Research Group Biomarkers for Infectious Diseases

Research Group Biomarkers for Infectious Diseases

The Research Group Biomarkers for Infectious Diseases aims to identify more accurate diagnostic, prognostic and predictive host biomarkers for infectious diseases and the vaccine response. The clinical aims of the group are to help select the most effective, individualized treatment as early as possible, aiming to streamline the use of anti-infectives (improve anti-infective stewardship) and to improve clinical outcome.

In addition, the researchers try to identify individuals that are at high risk of a non-response to a given vaccination and would therefore benefit from alternative vaccination strategies, for example higher doses, more frequent applications, adjuvanted vaccines or next-generation vaccines.

We put particular emphasis on supporting the mission of the CIIM and to maximize collaborations with MHH clinicians and the CRC Core Facility and Biobank. Through these collaborations, we  have access to biosamples such as peripheral blood cells, plasma, or cerebrospinal fluid from patients and the respective healthy controls and disease controls (disease with similar symptoms but different etiology). Our approach to biomarker discovery is based on unbiased (“hypothesis free”) profiling of biosamples, in particular using mass spectrometry and RNA sequencing. We also investigate potential roles in pathogenesis of the most promising biomarkers, as they or the associated metabolic pathways may constitute –in addition to the pathogens- therapeutic targets for adjuvant therapies. Molecules whose concentrations are decreased in patients could potentially even be used as therapeutics (e.g., the research project below on influenza vaccination).


How the body produces an endogenous antibiotic with anti-inflammatory effects

HZI and TWINCORE researchers give insights into itaconic acid synthesis For a long time, itaconic acid was only known as a metabolic product of fungi. Its function was unknown, but for decades it has been used industrially for...

27. March 2018

New diagnostic approach for meningoencephalitis by biomarkers

Unser Gehirn ist ein Hochsicherheitstrakt, das mit der Blut-Hirn-Schranke eine sehr effektive Barriere gegen Schadstoffe und Krankheitserreger errichtet hat. Trotzdem kann diese überwunden werden: Beispielsweise vom ...

13. February 2013

13 February 2013 New hope in fight against multi-resistant germs

International antibiotics study: HZI receives Euro 6m funding An increasing number of bacteria is evolving antibiotic resistance. Much-feared representatives of this steadily growing group include Staphylococci strains. At...